These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3131176)

  • 1. In vivo induction of gliadin-mediated enterocyte damage in rats by the mannosidase inhibitor, swainsonine: a possible animal model for celiac disease.
    Köttgen E; Beiswenger M; James LF; Bauer C
    Gastroenterology; 1988 Jul; 95(1):100-6. PubMed ID: 3131176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificities of rat kidney lysosomal and cytosolic alpha-D-mannosidases and effects of swainsonine suggest a role of the cytosolic enzyme in glycoprotein catabolism.
    Tulsiani DR; Touster O
    J Biol Chem; 1987 May; 262(14):6506-14. PubMed ID: 3106356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swainsonine induces the production of hybrid glycoproteins and accumulation of oligosaccharides in male reproductive tissues of the rat.
    Tulsiani DR; Skudlarek MD; Orgebin-Crist MC
    Biol Reprod; 1990 Jul; 43(1):130-8. PubMed ID: 2118392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swainsonine is a useful tool to monitor the intracellular traffic of N-linked glycoproteins as a function of the state of enterocytic differentiation of HT-29 cells.
    Houri JJ; Ogier-Denis E; Bauvy C; Aubery M; Sapin C; Trugnan G; Codogno P
    Eur J Biochem; 1992 May; 205(3):1169-74. PubMed ID: 1577000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swainsonine, a potent mannosidase inhibitor, elevates rat liver and brain lysosomal alpha-D-mannosidase, decreases Golgi alpha-D-mannosidase II, and increases the plasma levels of several acid hydrolases.
    Tulsiani DR; Touster O
    Arch Biochem Biophys; 1983 Jul; 224(2):594-600. PubMed ID: 6408990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of hybrid glycoproteins and accumulation of oligosaccharides in the brain of sheep and pigs administered swainsonine or locoweed.
    Tulsiani DR; Broquist HP; James LF; Touster O
    Arch Biochem Biophys; 1988 Aug; 264(2):607-17. PubMed ID: 3135781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swainsonine: an inhibitor of glycoprotein processing.
    Elbein AD; Solf R; Dorling PR; Vosbeck K
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7393-7. PubMed ID: 6801650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lutropin molecules synthesized by rat gonadotroph primary cultures in the presence of swainsonine: their oligosaccharides and biological potencies.
    Hattori M; Ozawa K; Wakabayashi K
    Mol Cell Endocrinol; 1988 Sep; 59(1-2):1-11. PubMed ID: 3143611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced peptide-binding capacities of small intestinal brush border membranes in celiac disease.
    Bolte G; Seilmeier W; Wieser H; Holm K; Beuermann K; Newport B; Stern M
    Pediatr Res; 1999 Dec; 46(6):666-70. PubMed ID: 10590021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and regulation of protein turnover: effect of the alpha-mannosidase inhibitor, swainsonine, on glycoprotein degradation.
    Segal HL; Winkler JR
    Curr Top Cell Regul; 1984; 24():229-49. PubMed ID: 6209068
    [No Abstract]   [Full Text] [Related]  

  • 11. The storage products in genetic and swainsonine-induced human mannosidosis.
    Cenci di Bello I; Dorling P; Winchester B
    Biochem J; 1983 Dec; 215(3):693-6. PubMed ID: 6419731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swainsonine inhibits macrophage receptor-mediated uptake and degradation of a mannosyl-oligosaccharide.
    Arumugham RG; Tanzer ML
    Biochem Biophys Res Commun; 1983 Nov; 116(3):922-30. PubMed ID: 6418175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked differences in the swainsonine inhibition of rat liver lysosomal alpha-D-mannosidase, rat liver Golgi mannosidase II, and jack bean alpha-D-mannosidase.
    Tulsiani DR; Broquist HP; Touster O
    Arch Biochem Biophys; 1985 Jan; 236(1):427-34. PubMed ID: 3917650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship of swainsonine. Inhibition of human alpha-mannosidases by swainsonine analogues.
    Cenci di Bello I; Fleet G; Namgoong SK; Tadano K; Winchester B
    Biochem J; 1989 May; 259(3):855-61. PubMed ID: 2499316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliadin binding to rat and human enterocytes.
    Colyer J; Kumar PJ; Waldron NM; Clark ML; Farthing MJ
    Clin Sci (Lond); 1987 May; 72(5):593-8. PubMed ID: 3581685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal hydrolases in macrophages exposed to swainsonine.
    Greenaway VA; Jessup W; Dean RT; Dorling PR
    Biochim Biophys Acta; 1983 Jul; 762(4):569-76. PubMed ID: 6223666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparagine-linked glycoprotein biosynthesis in rat epididymis. Presence of a mannosidase II-like enzyme.
    Skudlarek MD; Orgebin-Crist MC; Tulsiani DR
    Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):213-21. PubMed ID: 1906709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of alpha-D-mannosidases in the biosynthesis and catabolism of glycoproteins.
    Winchester B
    Biochem Soc Trans; 1984 Jun; 12(3):522-4. PubMed ID: 6428944
    [No Abstract]   [Full Text] [Related]  

  • 19. Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes.
    Bowlin TL; Sunkara PS
    Biochem Biophys Res Commun; 1988 Mar; 151(2):859-64. PubMed ID: 3126744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human lysosomal alpha(1----6)-mannosidase active on the branched trimannosyl core of complex glycans.
    Daniel PF; Evans JE; De Gasperi R; Winchester B; Warren CD
    Glycobiology; 1992 Aug; 2(4):327-36. PubMed ID: 1421754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.